Ablynx Competitors and Similar CompaniesClear all
ImmunoGen's competitors and similar companies include Innate Pharma.
 ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. |  Innate Pharma Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. | |
Founding Date | Founding Date 1981 | Founding Date 1999 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Waltham, US HQ | Locations Marseille, FR HQ Rockville, US |
Employees | Employees 277161% increase | Employees 181 |
Valuation ($) | Valuation ($) 8.7 b | Valuation ($) 148.6 m |
Financial | ||
Revenue (est.) | Revenue (est.) $108.8m (FY, 2022) | Revenue (est.) €2.8m (FY, 2025) |
Cost of goods | Cost of goods $176k (FY, 2022) | Cost of goods €266k (FY, 2025) |
Gross profit | Gross profit $108.6m (FY, 2022) | Gross profit €8.7m (FY, 2025) |
Net income | Net income ($222.9m) (FY, 2022) | Net income (€49.2m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 56m | Total funding raised $ 94.1m |
For sources of this data, please see the company profile
View Company Profiles
Innate Pharma
HQ
Marseille, FR
Employees
181
Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
View company